Loading...
| A10312 | Pages: 240 | Feb 2021 | 1123 Views | | |
| Author(s) : Surabhi Pandey , Onkar Sumant | Tables: 112 | Charts: 41 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cough Syrup Market
Request Now !The global cough syrup market size was valued at $5,232.73 million in 2019, and is projected to reach $6,108.25 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.
Cough syrups are used to treat coughs that occur when one has an upper respiratory tract infection (URTI). Moreover, a cough can also be a symptom of other conditions such as asthma or lung diseases. Cough syrups are often divided into those for a dry cough and those for a chesty cough. It is thought that cough syrups do not really work. However, some people feel that they work for them and are reasonably safe medicines. Cough syrups are sweet medicated liquids used to relieve coughing. Children who are aged 6 years and younger should only be given simple cough mixtures such as glycerin, honey, and lemon, or only a prescribed cough syrup.
Get more information on this report : Request Sample Pages
Cough syrup is prescribed by doctors or available over-the-counter for patients with sneezing, common cold, runny nose, and other respiratory allergies. A cough syrup ingredient has pro-viral properties and as per scientists, it should be avoided by people infected by the coronavirus. The medication “do not take” list for coronavirus symptoms released by the scientists includes dextromethorphan, an over-the-counter cough suppressant that is commonly used in cold medicines, especially cough syrup. Moreover, a new research paper published in the journal Nature found that dextromethorphan might increase the replication of SARS-CoV-2, the virus that causes COVID-19. Moreover, the coronavirus is able to replicate and hijack the cells, which can make one feel sicker. As a result, researchers caution against using cough syrup and other cold & flu medicines that contain dextromethorphan specifically.
The growth of the global cough syrup market is majorly driven by rise in respiratory disorders. In addition, increase in geriatric population and immense air pollution further drive the growth of the market. However, misuse of cough syrup and stringent regulatory framework hinder the market growth. Conversely, high market potential in untapped emerging economies is expected to provide lucrative growth opportunities for the cough syrup market growth.
The cough syrup market is segmented on the basis of product type, age group, distribution channel, and region. By product, the market is divided into expectorants, cough suppressants/antitussives, and combination medications. On the basis of age group, the cough syrup market is bifurcated into pediatric and adult. By distribution channel, the market is distributed into retail pharmacy, hospital pharmacy, and online pharmacy. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By product type, the cough suppressants/antitussives segment held the largest share in 2019, and is expected to maintain its dominance over the forecast period. This is attributed to commonly available dextromethorphan at chemist stores or pharmacies.
Get more information on this report : Request Sample Pages
By age group, the adult segment is expected to register the highest CAGR during the forecast period due to rising geriatric population and increasing respiratory illness among adults. Furthermore, it is also attributed to the fact that cough syrups are mainly recommended to the adult age group by the government whereas the pediatric age group cannot be provided with OTC cough syrups without any prescription.
Get more information on this report : Request Sample Pages
By region, the cough syrup market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027 due to easier availability of cough syrups at retail pharmacies, rise in geriatric population, and less stricter laws regarding the abuse of cough & cold medicines in the region. However, LAMEA is expected to register the highest CAGR during the forecast period as governments are investing in the development of healthcare infrastructure and increasing cases of respiratory disorders.
Get more information on this report : Request Sample Pages
Some of the key players operating in the cough syrup market include Novartis AG, Pfizer, Inc., Merck KGaA, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Acella Pharmaceuticals, LLC, Reckitt Benckiser Group PLC, Sanofi, Procter & Gamble, and Abbott Laboratories. The other players (not profiled in the report) in the value chain include Sun Pharmaceutical Industries, Shanghai Pharmaceutical, AstraZaneca, and others.
Key Benefits For Stakeholders
Key Market Segments
By Product Type
By Age Group
By Distribution Channel
By Region
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
1.4.4.Primary research
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top player positioning, 2019
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increasing number of patients suffering from respiratory disease
3.4.1.2.Advancements in cough syrup product
3.4.1.3.Rise in elderly population
3.4.2.Restraints
3.4.2.1.Cough syrup abuse
3.4.2.2.Stringent rules and regulation in the developed countries
3.4.3.Opportunity
3.4.3.1.Emerging market
3.5.COVID-19 impact analysis for cough syrup market
CHAPTER 4:COUGH SYRUP MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Expectorants
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Cough suppressants
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Combination medications
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:COUGH SYRUP MARKET, BY AGE GROUP
5.1.Overview
5.1.1.Market size and forecast
5.2.Pediatric
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Adult
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Retail Pharmacy
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Hospital Pharmacy
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Online Pharmacy
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:COUGH SYRUP MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America Cough syrup market, by country
7.2.2.1.U.S. Market size and forecast, by product type
7.2.2.2.U.S. Market size and forecast, by age group
7.2.2.3.U.S. Market size and forecast, by distribution channel
7.2.2.4.Canada Market size and forecast, by product type
7.2.2.5.Canada Market size and forecast, by age group
7.2.2.6.Canada Market size and forecast, by distribution channel
7.2.2.7.Mexico Market size and forecast, by product type
7.2.2.8.Mexico Market size and forecast, by age group
7.2.2.9.Mexico Market size and forecast, by distribution channel
7.2.3.North America market size and forecast, by product type
7.2.4.North America market size and forecast, by age group
7.2.5.North America Market size and forecast, by distribution channel
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Cough syrup market, by country
7.3.2.1.Germany Market size and forecast, by product type
7.3.2.2.Germany Market size and forecast, by age group
7.3.2.3.Germany Market size and forecast, by distribution channel
7.3.2.4.France Market size and forecast, by product type
7.3.2.5.France Market size and forecast, by age group
7.3.2.6.France Market size and forecast, by distribution channel
7.3.2.7.UK Market size and forecast, by product type
7.3.2.8.UK Market size and forecast, by age group
7.3.2.9.UK Market size and forecast, by distribution channel
7.3.2.10.Italy Market size and forecast, by product type
7.3.2.11.Italy Market size and forecast, by age group
7.3.2.12.Italy Market size and forecast, by distribution channel
7.3.2.13.Spain Market size and forecast, by product type
7.3.2.14.Spain Market size and forecast, by age group
7.3.2.15.Spain Market size and forecast, by distribution channel
7.3.2.16.Rest of Europe Market size and forecast, by product type
7.3.2.17.Rest of Europe Market size and forecast, by age group
7.3.2.18.Rest of Europe Market size and forecast, by distribution channel
7.3.3.Europe market size and forecast, by product type
7.3.4.Europe market size and forecast, by age group
7.3.5.Europe Market size and forecast, by distribution channel
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Cough syrup market, by country
7.4.2.1.Japan Market size and forecast, by product type
7.4.2.2.Japan Market size and forecast, by age group
7.4.2.3.Japan Market size and forecast, by distribution channel
7.4.2.4.China Market size and forecast, by product type
7.4.2.5.China Market size and forecast, by age group
7.4.2.6.China Market size and forecast, by distribution channel
7.4.2.7.Australia Market size and forecast, by product type
7.4.2.8.Australia Market size and forecast, by age group
7.4.2.9.Australia Market size and forecast, by distribution channel
7.4.2.10.India Market size and forecast, by product type
7.4.2.11.India Market size and forecast, by age group
7.4.2.12.India Market size and forecast, by distribution channel
7.4.2.13.Rest of Asia-Pacific Market size and forecast, by product type
7.4.2.14.Rest of Asia-Pacific Market size and forecast, by age group
7.4.2.15.Rest of Asia-Pacific Market size and forecast, by distribution channel
7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by age group
7.4.5.Asia-Pacific Market size and forecast, by distribution channel
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Cough syrup market, by country
7.5.2.1.Brazil Market size and forecast, by product type
7.5.2.2.Brazil Market size and forecast, by age group
7.5.2.3.Brazil Market size and forecast, by distribution channel
7.5.2.4.Saudi Arabia Market size and forecast, by product type
7.5.2.5.Saudi Arabia Market size and forecast, by age group
7.5.2.6.Saudi Arabia Market size and forecast, by distribution channel
7.5.2.7.South Africa Market size and forecast, by product type
7.5.2.8.South Africa Market size and forecast, by age group
7.5.2.9.South Africa Market size and forecast, by distribution channel
7.5.2.10.Rest of LAMEA Market size and forecast, by product type
7.5.2.11.Rest of LAMEA Market size and forecast, by age group
7.5.2.12.Rest of LAMEA Market size and forecast, by distribution channel
7.5.3.LAMEA market size and forecast, by product type
7.5.4.LAMEA market size and forecast, by age group
7.5.5.LAMEA Market size and forecast, by distribution channel
CHAPTER 8:COMPANY PROFILES
8.1.Abbott Laboratories
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.Acella Pharmaceuticals, LLC
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.3.GlaxoSmithKline plc
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.Johnson & Johnson services Inc.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.Merck KGaA
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.Novartis International AG
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.Pfizer Inc.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.Procter & Gamble
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.Reckitt Benckiser Group Plc.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.Sanofi
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 02.COUGH SYRUP MARKET FOR EXPECTORANTS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.COUGH SYRUP MARKET FOR COUGH SUPPRESSANTS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.COUGH SYRUP MARKET FOR COMBINATION MEDICATIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 06.COUGH SYRUP MARKET FOR PEDIATRIC, BY REGION, 2019–2027 ($MILLION)
TABLE 07.COUGH SYRUP MARKET FOR ADULT, BY REGION, 2019–2027 ($MILLION)
TABLE 08.COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 09.COUGH SYRUP MARKET FOR RETAIL PHARMACY, BY REGION, 2019–2027 ($MILLION)
TABLE 10.COUGH SYRUP MARKET FOR HOSPITAL PHARMACY, BY REGION, 2019–2027 ($MILLION)
TABLE 11.COUGH SYRUP MARKET FOR ONLINE PHARMACY, BY REGION, 2019–2027 ($MILLION)
TABLE 12.COUGH SYRUP MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 14.U.S. COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 15.U.S. COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 16.U.S. COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 17.CANADA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 18.CANADA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 19.CANADA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 20.MEXICO COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 22.MEXICO COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 24.NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 25.NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 26.EUROPE COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 27.GERMANY COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 28.GERMANY COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 29.GERMANY COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 30.FRANCE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 31.FRANCE COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 32.FRANCE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 33.UK COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 34.UK COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 35.UK COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 36.ITALY COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 37.ITALY COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 38.ITALY COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 39.SPAIN COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 40.SPAIN COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 41.SPAIN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 42.REST OF EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 43.REST OF EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 44.REST OF EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 45.EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 46.EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 47.EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 48.ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 49.JAPAN COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 50.JAPAN COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 51.JAPAN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 52.CHINA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 53.CHINA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 54.CHINA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 55.AUSTRALIA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 56.AUSTRALIA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 57.AUSTRALIA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 58.INDIA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 59.INDIA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 60.INDIA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 61.REST OF ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 62.REST OF ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 63.REST OF ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 64.ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 65.ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 66.ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 67.LAMEA COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 68.BRAZIL COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 69.BRAZIL COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 70.BRAZIL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 71.SAUDI ARABIA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 72.SAUDI ARABIA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 73.SAUDI ARABIA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 74.SOUTH AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 75.SOUTH AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 76.SOUTH AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 77.REST OF LAMEA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 78.REST OF LAMEA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 79.REST OF LAMEA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 80.LAMEA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 81.LAMEA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 82.LAMEA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 83.ABBOTT: COMPANY SNAPSHOT
TABLE 84.ABBOTT: OPERATING SEGMENTS
TABLE 85.ABBOTT: PRODUCT PORTFOLIO
TABLE 86.ACELLA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 87.ACELLA PHARMACEUTICALS: OPERATING SEGMENTS
TABLE 88.ACELLA PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 89.GSK: COMPANY SNAPSHOT
TABLE 90.GSK: OPERATING SEGMENTS
TABLE 91.GSK: PRODUCT PORTFOLIO
TABLE 92.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 93.J&J: OPERATING SEGMENTS
TABLE 94.J&J: PRODUCT PORTFOLIO
TABLE 96.MERCK: OPERATING SEGMENTS
TABLE 97.MERCK: PRODUCT PORTFOLIO
TABLE 98.NVS: COMPANY SNAPSHOT
TABLE 99.NOVARTIS: OPERATING SEGMENTS
TABLE 100.NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 101.PFIZER: COMPANY SNAPSHOT
TABLE 102.PFIZER: OPERATING SEGMENTS
TABLE 103.PFIZER: PRODUCT PORTFOLIO
TABLE 104.P&G: COMPANY SNAPSHOT
TABLE 105.P&G: OPERATING SEGMENTS
TABLE 106.P&G: PRODUCT PORTFOLIO
TABLE 107.RB: COMPANY SNAPSHOT
TABLE 108.RB: OPERATING SEGMENTS
TABLE 109.RB : PRODUCT PORTFOLIO
TABLE 110.SANOFI: COMPANY SNAPSHOT
TABLE 111.SANOFI: OPERATING SEGMENTS
TABLE 112.SANOFI: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.COUGH SYRUP MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS IN COUGH SYRUPMARKET
FIGURE 03.TOP PLAYER POSITIONING, 2019
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE THREAT OF SUBSTITUTION
FIGURE 08.MODERATE COMPETITIVE RIVALRY
FIGURE 09.DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 10.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR EXPECTORANTS BY COUNTRY, 2019–2027 (%)
FIGURE 11.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR COUGH SUPPRESSANTS BY COUNTRY, 2019–2027 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR COMBINATION MEDICATIONS BY COUNTRY, 2019–2027 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR PEDIATRIC BY COUNTRY, 2019–2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR ADULT BY COUNTRY, 2019–2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR RETAIL PHARMACY, BY COUNTRY, 2019–2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR HOSPITAL PHARMACY, BY COUNTRY, 2019–2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR ONLINE PHARMACY BY COUNTRY, 2019–2027 (%)
FIGURE 18.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 19.ABBOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 20.ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 21.GSK: NET SALES, 2017–2019 ($MILLION)
FIGURE 22.GSK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 23.GSK: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 24.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.J&J: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 26.J&J: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 27.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.MERCK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.NOVARTIS: NET SALES, 2018–2019 ($MILLION)
FIGURE 30.NOVARTIS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 31.NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 32.PFIZER: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.PFIZER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.PFIZER: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 35.P&G: NET SALES, 2017–2019 ($MILLIO)
FIGURE 36.RB: NET SALES, 2018–2019 ($MILLION)
FIGURE 37.RB: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 38.RB: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 39.SANOFI: NET SALES, 2017 TO 2019 ($MILLION)
FIGURE 40.SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.SANOFI: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
The utilization of cough syrup is expected to witness a significant rise with increase in prevalence of common cold and respiratory illness. Further, cough syrup is preferred more in some conditions over the other route of administration. Moreover, many cough and cold products for children have more than one ingredient, which can increase the chances of accidental overdose if taken, which boosts the growth of the market. In developing countries, cough syrups are easily available without any prescription over-the-counter, which drives the growth of the cough syrup market.
The combination medications segment is expected to register the highest CAGR during the forecast period as combination drugs are more effective in treating dry cough, wet cough, and other respiratory illness. Retail pharmacies dominate the market as prescription is not necessary, and cough syrups are easily available in drug stores. In addition, physicians prescribe the OTC cough syrups for common cold and other respiratory diseases, thereby driving the growth of the cough syrup market.
A. The major factor that fuels the growth of the Cough Syrup Market includes increase in respiratory illness and surge in geriatric population.
A. Cough Suppressants segment is the most influencing segment, owing to the easier avaibility and increasing geriatric populations in the developing countries.
A. Top companies such as, Novartis AG, Pfizer, Inc., Merck KGaA, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Acella Pharmaceuticals, LLC, Reckitt Benckiser Group PLC, Sanofi, Procter & Gamble, and Abbott Laboratories
A. The total market value of Cough Syrup Market is $5,233 million in 2019.
A. The forcast period for Cough Syrup Market is 2020 to 2027
A. The market value of Cough Syrup Market in 2020 is $5,029 million.
A. The base year is 2019 in Cough Syrup Market
A. Yes, Cough Syrup companies are profiled in the report.
Enterprise
License/PDF
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
